Diseases of the Pleura and Mediastinum

Orit Kaidar-Person; Timothy Zagar; Benjamin E. Haithcock; Jared Weiss

doi:10.1016/B978-0-323-47674-4.00070-0

Diseases of the Pleura and Mediastinum

Orit Kaidar-Person
, Timothy Zagar
, Benjamin E. Haithcock
, Jared Weiss

Rambam Health Care Campus Israel
Northeastern Radiation Oncology
University of North Carolina at Chapel Hill

Research output: Chapter in Book/Report/Conference proceeding › Chapter › peer-review

1 Scopus citations

Abstract

Malignant pleural mesothelioma is a rare disease. Ninety percent of cases are attributed to asbestos exposure. Surgical options include extrapleural pneumonectomy or pleurectomy and decortication. The role of chemotherapy and radiation in resectable disease is controversial. For unresectable or metastatic disease, the standard treatment is the combination of a platinum drug and an antifolate drug.

Original language	English
Title of host publication	Abeloff’s Clinical Oncology
Publisher	Elsevier
Pages	1159-1173.e4
ISBN (Electronic)	9780323476744
DOIs	https://doi.org/10.1016/B978-0-323-47674-4.00070-0
State	Published - 1 Jan 2019
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

Malignant pleural effusion
Malignant pleural mesothelioma
Thymic carcinoid
Thymic carcinoma
Thymoma

Access to Document

10.1016/B978-0-323-47674-4.00070-0

Cite this

@inbook{72e06904f79249ad81861e7abf7e900a,

title = "Diseases of the Pleura and Mediastinum",

abstract = "Malignant pleural mesothelioma is a rare disease. Ninety percent of cases are attributed to asbestos exposure. Surgical options include extrapleural pneumonectomy or pleurectomy and decortication. The role of chemotherapy and radiation in resectable disease is controversial. For unresectable or metastatic disease, the standard treatment is the combination of a platinum drug and an antifolate drug.",

keywords = "Malignant pleural effusion, Malignant pleural mesothelioma, Thymic carcinoid, Thymic carcinoma, Thymoma",

author = "Orit Kaidar-Person and Timothy Zagar and Haithcock, \{Benjamin E.\} and Jared Weiss",

note = "Publisher Copyright: {\textcopyright} 2020 Elsevier Inc.",

year = "2019",

month = jan,

day = "1",

doi = "10.1016/B978-0-323-47674-4.00070-0",

language = "אנגלית",

pages = "1159--1173.e4",

booktitle = "Abeloff{\textquoteright}s Clinical Oncology",

publisher = "Elsevier",

address = "הולנד",

}

TY - CHAP

T1 - Diseases of the Pleura and Mediastinum

AU - Kaidar-Person, Orit

AU - Zagar, Timothy

AU - Haithcock, Benjamin E.

AU - Weiss, Jared

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Malignant pleural mesothelioma is a rare disease. Ninety percent of cases are attributed to asbestos exposure. Surgical options include extrapleural pneumonectomy or pleurectomy and decortication. The role of chemotherapy and radiation in resectable disease is controversial. For unresectable or metastatic disease, the standard treatment is the combination of a platinum drug and an antifolate drug.

AB - Malignant pleural mesothelioma is a rare disease. Ninety percent of cases are attributed to asbestos exposure. Surgical options include extrapleural pneumonectomy or pleurectomy and decortication. The role of chemotherapy and radiation in resectable disease is controversial. For unresectable or metastatic disease, the standard treatment is the combination of a platinum drug and an antifolate drug.

KW - Malignant pleural effusion

KW - Malignant pleural mesothelioma

KW - Thymic carcinoid

KW - Thymic carcinoma

KW - Thymoma

UR - https://www.scopus.com/pages/publications/85123674761

U2 - 10.1016/B978-0-323-47674-4.00070-0

DO - 10.1016/B978-0-323-47674-4.00070-0

M3 - ???researchoutput.researchoutputtypes.contributiontobookanthology.chapter???

AN - SCOPUS:85123674761

SP - 1159-1173.e4

BT - Abeloff’s Clinical Oncology

PB - Elsevier

ER -

Diseases of the Pleura and Mediastinum

Abstract

UN SDGs

Keywords

Access to Document

Other files and links

Fingerprint

Cite this